A new RFID tag device being developed by SenoRx, a company that is exclusively focused on breast cancer intervention, could soon be the next innovative product in women’s oncological needs.
According to CNN, breast cancer is the second most frequently diagnosed cancer among women and SenoRx announced that it was conducting research for a new RFID tag and accompanying handheld reader which the company believes may help in lesion localization.
Unlike similar procedures, SenoRx’s RFID tag is contained inside the patient’s breast, so there is no protruding wire, thus reducing the risk of infection and the urgency to perform surgery in the same day.
In the current course of treatment it is imperative that a patient rapidly go from radiologist to surgeon to minimize risk of infection and patient discomfort. The benefits of the device may offer significant improvements in scheduling logistics and workflow between the radiologist and surgeons.
To read more click here.